chrX-103500501-C-T
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_080879.3(RAB40A):c.256G>A(p.Gly86Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000455 in 1,208,866 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 16 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G86V) has been classified as Uncertain significance.
Frequency
Consequence
NM_080879.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000271 AC: 3AN: 110800Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 32986
GnomAD3 exomes AF: 0.0000437 AC: 8AN: 182949Hom.: 0 AF XY: 0.0000297 AC XY: 2AN XY: 67453
GnomAD4 exome AF: 0.0000474 AC: 52AN: 1098066Hom.: 0 Cov.: 33 AF XY: 0.0000440 AC XY: 16AN XY: 363444
GnomAD4 genome AF: 0.0000271 AC: 3AN: 110800Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 32986
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.256G>A (p.G86S) alteration is located in exon 3 (coding exon 1) of the RAB40A gene. This alteration results from a G to A substitution at nucleotide position 256, causing the glycine (G) at amino acid position 86 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at